-
Board Certification
American Board of Dermatology (Dermatology)American Board of Dermatology (Sub: Micrographic Dermatologic Surgery)Patient Rating
4.9 /5( out of 418 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
January 24, 2025HUNTSMAN CANCER CENTERDr Tristani-Firouzi is exceptionally skilled and kind. I trust her completely.
January 23, 2025MIDVALLEYDr. Tristani is an excellent dermatologist. I have trusted her with my skin for years and have always been happy and satisfied with the results.
January 14, 2025HUNTSMAN CANCER CENTERPayam is an amazing doctor ! I would trust her with my life !
January 10, 2025MIDVALLEYGreat doctor! Very nice and always answers my questions.
January 09, 2025HUNTSMAN CANCER CENTERTotal professional
January 08, 2025UNIVERSITY HOSPITALDr Tristani is AMAZING!
January 04, 2025MIDVALLEYI have been receiving dermatology care from Dr. Tristani for many years and have always felt valued as a patient and a person. She is both personable and highly professional.
January 01, 2025UNIVERSITY HOSPITALI thank Dr. Tristani for her kindness and for the care given to me. Thank you so much and wishing you all the best!
December 20, 2024HUNTSMAN CANCER CENTERGreat work.
-
Board Certification and Academic Information
Academic Departments Dermatology -Primary Board Certification American Board of Dermatology (Dermatology)American Board of Dermatology (Sub: Micrographic Dermatologic Surgery)Education history
Fellowship Mohs Micrographic Surgery - Ογ½ΆΚΣΖ΅ of Utah School of Medicine Fellow Residency Dermatology - Ογ½ΆΚΣΖ΅ of Utah School of Medicine Resident Fellowship Dermatology - Ογ½ΆΚΣΖ΅ of Utah School of Medicine Fellow Internship Internal Medicine - Ογ½ΆΚΣΖ΅ of Utah School of Medicine Intern Professional Medical Medicine - Ογ½ΆΚΣΖ΅ of Minnesota M.D. Graduate Training Laboratory Medicine and Pathology - Ογ½ΆΚΣΖ΅ of Minnesota Master's Undergraduate Medical Technology - Ογ½ΆΚΣΖ΅ of Minnesota B.S. Selected Publications
Journal Article
- Donigan JM, Srivastava D, Maher I, Abdelmalek M, Bar AA, Blalock TW, Bordeaux JS, Brodland DG, Carroll BT, Council ML, Duffy K, Fathi R, Golda N, Johnson-Jahangir H, Konda S, Leitenberger JJ, Moye M, Nelson JL, Patel VA, Shaffer JJ, Soltani-Arabshahi R, Tristani-Firouzi P, Tschetter AJ, Nijhawan RI (2020). Opioid Prescribing Recommendations After Mohs Micrographic Surgery and Reconstruction: A Delphi Consensus. Dermatol Surg, 47(2), 167-169. ()
- Donigan JM, Franco AI, Stoddard GJ, Hedderman A, Tristani-Firouzi P, Bowen GM, Millican EA, Duffy KL (2018). Opioid Prescribing Patterns After Micrographic Surgery: A Follow-up Retrospective Chart Review. Dermatol Surg, 45(4), 508-513. ()
- Saluja SS, Walker ML, Summers EM, Tristani-Firouzi P, Smart DR (2017). Safety of non-ablative fractional laser for acne scars within 1 month after treatment with oral isotretinoin: A randomized split-face controlled trial. Lasers Surg Med, 49(10), 886-890. ()
- Hyde MA, Hadley ML, Tristani-Firouzi P, Goldgar D, Bowen GM (2012). A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions. Arch Dermatol, 148(5), 592-6. ()
- Hadley J, Tristani-Firouzi P, Hull C, Florell S, Cotter M, Hadley M (2012). Results of an investigator-initiated single-blind split-face comparison of photodynamic therapy and 5% imiquimod cream for the treatment of actinic keratoses. Dermatol Surg, 38(5), 722-7. ()
- Bowen AR, Burt L, Boucher K, Tristani-Firouzi P, Florell SR (2012). Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: a pilot study. J Cutan Pathol, 39(2), 243-50. ()
- Foo CW, Tristani-Firouzi P (2011). Topical modalities for treatment and prevention of postsurgical hypertrophic scars. Facial Plast Surg Clin North Am, 19(3), 551-7. ()
- Hadley JC, Tristani-Firouzi P, Florell SF, Bowen GM, Hadley ML (2009). Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins. Dermatol Surg, 35(12), 2019-24. ()
- Duffy KL, Bowen AR, Tristani-Firouzi P, Florell SR, Hadley ML (2009). Eccrine syringofibroadenoma-like change adjacent to a squamous cell carcinoma: potential histologic pitfall in Mohs micrographic surgery. Dermatol Surg, 35(3), 519-22. ()
- Duffy KL, Florell SR, Tristani-Firouzi P, Bowen AR, Hadley ML (2009). Syringocystadenomatous-like change adjacent to a squamous cell carcinoma: Potential Mohs Micrographic Surgery pitfall. Dermatol Surg, 35(3), 519-22.
- Duffy KL, McKenna JK, Hadley ML, Tristani-Firouzi P (2009). Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size. Dermatol Surg, 35(1), 30-3. ()
- Hadley JC, Tristani-Firouzi P, Florell SF, Bowen GM, Hadley ML (2009). Case Series of Multiply Recurrent Reactive Keratoacanthoma Developing at Surgical Margins. Dermatol Surg, 35(12), 2019-24.
-
News & Podcasts
Podcasts
( out of 418 reviews )